We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Algorithm Outperforms Human Experts in Identifying Cervical Precancer

By HospiMedica International staff writers
Posted on 24 Jan 2019
Researchers from the National Institutes of Health (Bethesda, MA, USA) have developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention. More...
The artificial intelligence (AI) approach, called automated visual evaluation, could potentially revolutionize cervical cancer screening, especially in low-resource settings.

Health workers can easily perform automated visual evaluation by using a cell phone or similar camera device for cervical screening and treatment during a single visit. Additionally, the approach can be performed with minimal training, making it ideal for countries with limited health care resources, where cervical cancer is a leading cause of illness and death among women.

The researchers developed the method by using comprehensive datasets to "train" a deep, or machine, learning algorithm to recognize patterns in complex visual inputs, such as medical images. They created the algorithm by using more than 60,000 cervical images from a photo archive of the National Cancer Institute (NCI) that was collected during a cervical cancer screening study carried out in Costa Rica in the 1990s. More than 9,400 women participated in that population study, with follow up lasting for up to 18 years. The prospective nature of the study allowed the researchers to gain nearly complete information on which cervical changes became precancers and which did not. The photos were digitized and used to train a deep learning algorithm so that it could distinguish between the cervical conditions requiring treatment and those not requiring treatment.

The researchers now plan to further train the algorithm on a sample of representative images of cervical precancers and normal cervical tissue from women in communities around the world, using a variety of cameras and other imaging options with the aim of creating the best possible algorithm for common, open use.

"Our findings show that a deep learning algorithm can use images collected during routine cervical cancer screening to identify precancerous changes that, if left untreated, may develop into cancer," said Mark Schiffman, M.D, M.P.H., of NCI’s Division of Cancer Epidemiology and Genetics, and senior author of the study. "In fact, the computer analysis of the images was better at identifying precancer than a human expert reviewer of Pap tests under the microscope (cytology)."

"When this algorithm is combined with advances in HPV vaccination, emerging HPV detection technologies, and improvements in treatment, it is conceivable that cervical cancer could be brought under control, even in low-resource settings," said Maurizio Vecchione, executive vice president of Global Good, a fund at Intellectual Ventures, which collaborated with the NCI investigators for creating this approach.

Related Links:
National Institutes of Health


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.